AMLX icon

Amylyx Pharmaceuticals

Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$20
29% upside
High target

3 analyst ratings

positive
neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
BofA Securities
BofA Securities
Geoff Meacham
100% 1-yr AMLX win rate
3 Oct ‘25 13 days ago
Goldman Sachs
Goldman Sachs
Corinne Johnson
100% 1-yr AMLX win rate
16 Sep ‘25 29 days ago
Guggenheim
Guggenheim
Seamus Fernandez
100% 1-yr AMLX win rate
15 Sep ‘25 1 month ago